Study To Evaluate Adverse Events And Change In Disease Activity In Adult Participants With B-Cell Malignancies Receiving Oral Abbv-525 Tablets
Posted Date: May 14, 2024
- Investigator: Zulfa Omer
- Specialties:
- Type of Study: Drug
B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this study is to assess safety, tolerability, pharmacokinetics and preliminary efficacy of ABBV-525 as a monotherapy.
Criteria:
Null
Keywords:
B-Cell
For More Information:
Emily Greve
NULL
cancer@uchealth.com